RKIP Regulates Differentiation-Related Features in Melanocytic Cells
Open Access
- 3 June 2020
- Vol. 12 (6), 1451
- https://doi.org/10.3390/cancers12061451
Abstract
Raf Kinase Inhibitor Protein (RKIP) has been extensively reported as an inhibitor of key signaling pathways involved in the aggressive tumor phenotype and shows decreased expression in several types of cancers. However, little is known about RKIP in melanoma or regarding its function in normal cells. We examined the role of RKIP in both primary melanocytes and malignant melanoma cells and evaluated its diagnostic and prognostic value. IHC analysis revealed a significantly higher expression of RKIP in nevi compared with early-stage (stage I–II, AJCC 8th) melanoma biopsies. Proliferation, wound healing, and collagen-coated transwell assays uncovered the implication of RKIP on the motility but not on the proliferative capacity of melanoma cells as RKIP protein levels were inversely correlated with the migration capacity of both primary and metastatic melanoma cells but did not alter other parameters. As shown by RNA sequencing, endogenous RKIP knockdown in primary melanocytes triggered the deregulation of cellular differentiation-related processes, including genes (i.e., ZEB1, THY-1) closely related to the EMT. Interestingly, NANOG was identified as a putative transcriptional regulator of many of the deregulated genes, and RKIP was able to decrease the activation of the NANOG promoter. As a whole, our data support the utility of RKIP as a diagnostic marker for early-stage melanomas. In addition, these findings indicate its participation in the maintenance of a differentiated state of melanocytic cells by modulating genes intimately linked to the cellular motility and explain the progressive decrease of RKIP often described in tumors.This publication has 71 references indexed in Scilit:
- RKIP Inhibition in Cervical Cancer Is Associated with Higher Tumor Aggressive Behavior and Resistance to Cisplatin TherapyPLOS ONE, 2013
- Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell linesOncology Letters, 2012
- Genetics and epigenetics of cutaneous malignant melanoma: A concert out of tuneBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012
- RAF-kinase inhibitor protein (RKIP) downregulation in esophageal cancer and its metastasesClinical & Experimental Metastasis, 2012
- Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in GliomasPLOS ONE, 2012
- Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expressionCancer Letters, 2010
- Reduction of Raf Kinase Inhibitor Protein Expression by Bcr-Abl Contributes to Chronic Myelogenous Leukemia ProliferationOnline Journal of Public Health Informatics, 2010
- C-Raf Is Associated with Disease Progression and Cell Proliferation in a Subset of MelanomasClinical Cancer Research, 2009
- Raf kinase inhibitory protein inhibits β-cell proliferationSurgery, 2004
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001